Galapagos NV (GLPG): Stock Price, Earnings & Key Metrics

Price

$28.88

return (12m)

p/e

4.50

p/bv

0.46

DIVIDEND YIELD

0.00%

GLPG price

Galapagos NV

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GLPG

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals GLPG

Valuation

P/E

4.50

Sector -4.15

Industry -4.15

P/BV

0.46

Sector 2.06

Industry 2.06

P/Revenue (PSR)

1.36

Sector -4.16

Industry -4.16

EV/EBITDA

-2.67

Sector -241.86

Industry -241.86

EV/EBIT

-2.67

Sector -671.75

Industry -671.75

P/EBITDA

4.74

Sector -4.30

Industry -4.30

P/EBIT

4.74

Sector -4.35

Industry -4.35

P/Total Assets

0.44

Sector 1.46

Industry 1.46

P/Net Current Assets

0.52

Sector -12.67

Industry -12.67

P/Working Capital

0.51

Sector -12.58

Industry -12.58

EPS

5.92

Sector -2.19

Industry -2.19

BVPS

57.41

Sector 1.92

Industry 1.92

Efficiency

Gross Margin

97.41%

Sector 36.44%

Industry 36.44%

EBITDA Margin

62.22%

Sector -16,748.51%

Industry -16,748.51%

EBIT Margin

62.22%

Sector -4,256,846.44%

Industry -4,256,846.44%

Operating Margin

46.52%

Sector -38.78%

Industry -38.78%

Net Profit Margins

30.19%

Sector -39.93%

Industry -39.93%

Asset Turnover

0.26

Sector 0.03

Industry 0.03

Profitability

ROE

10.31%

Sector -67.01%

Industry -67.01%

ROA

9.80%

Sector -66.28%

Industry -66.28%

ROIC

570.42%

Sector -2,917.75%

Industry -2,917.75%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

20.15

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-5.35

Sector -12,252,405.04

Industry -12,252,405.04

Net Debt / EBIT

-5.35

Sector -3.79

Industry -3.79

Net Debt / Equity

-0.93

Sector -33,290.93

Industry -33,290.93

Gross Debt / Equity

0.00

Sector 0.00

Industry 0.00

Equity/Assets

0.95

Sector 0.42

Industry 0.42

Liabilities/Assets

0.05

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-90.92%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Galapagos NV ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$28.88

Fair Value

$87.45

Upside Return potential.

202.79%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GLPG

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
GLPG Galapagos NV	$28.88	20.28%	0.00%	4.50	0.46	10.31%	30.19%
AZN AstraZeneca PLC	$204.64	53.45%	1.89%	25.20	5.52	21.93%	17.19%
JNJ Johnson & Johnson	$240.16	62.69%	2.08%	28.83	0.00	-%	21.48%
NBIX Neurocrine Biosciences Inc.	$130.81	43.95%	0.00%	25.46	5.00	19.62%	21.55%
ABEO Abeona Therapeutics Inc.	$5.19	12.83%	0.00%	6.09	2.78	45.63%	100.00%
PFE Pfizer Inc.	$27.11	32.71%	6.97%	18.76	1.55	8.29%	11.83%
ABBV AbbVie Inc.	$210.26	25.08%	2.61%	125.53	-69.01	-54.98%	5.79%
ABUS Arbutus Biopharma Corporation	$4.35	38.54%	0.00%	5.66	3.50	61.77%	83.94%
ACAD ACADIA Pharmaceuticals Inc.	$22.02	51.03%	0.00%	11.55	3.48	30.10%	34.30%
ADMA ADMA Biologics Inc.	$10.49	-45.93%	0.00%	12.58	5.33	42.37%	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GLPG Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Galapagos NV

Galapagos NV

Average Investor10 user rating

4.0 (0 people)

States of America

27 years

Founded: 1999

2015

Time since IPO - 11 years

1.304

Employees

Galapagos NV (States of America) is listed on the Nasdaq and has a market capitalization of $1.76 billion, with shareholders equity totaling $3.79 billion.

The company employs approximately 1.304 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, Galapagos NV reported $1.29 billion in revenue, generating net income of $390.83 million.

Key financial metrics include a P/E ratio of 4.50, a price-to-book (P/B) ratio of 0.46, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker GLPG.

Market cap

$1.76 billion

Net worth

$3.79 billion

$3,789,070,000.00

Assets

$3.99 billion

$3,988,900,000.00

Total Shares Outstanding

66.00 million

66,000,000

Average Daily Trading Volume

$176.84 Thousand

$176,843.66

Sector

Healthcare

Industry

Biotecnologia

GLPG

GLPG revenue and profits

Financial Results GLPG

DRAG THE FRAME TO SEE MORE DATA

GLPG cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$862.96 22,54% (12M)

P/E

21.66

0.39%

ROE

-570.98%

P/BV

-123.68

CAH - Cardinal Health

$214.95 38,63% (12M)

P/E

34.90

0.89%

ROE

-58.20%

P/BV

-20.31

JNJ - Johnson & Johnson

$240.16 47,25% (12M)

P/E

28.83

2.08%

ROE

P/BV

0.00

MRK - Merck & Co.

$119.96 46,43% (12M)

P/E

35.53

2.62%

ROE

19.45%

P/BV

6.91

AZN - AstraZeneca

$204.64 40,78% (12M)

P/E

25.20

1.89%

ROE

21.93%

P/BV

5.52

ABBV - AbbVie

$210.26 15,08% (12M)

P/E

125.53

2.61%

ROE

-54.98%

P/BV

-69.01

NVO - Novo Nordisk

$39.32 --40,26% (12M)

P/E

11.83

3.68%

ROE

60.40%

P/BV

7.14